These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Coronary reserve and cardiac output of patients with ischemic heart disease after measured exercise therapy as well as additional treatment with hexobendine]. Drews A Arzneimittelforschung; 1968 Aug; 18(8):1084-94. PubMed ID: 5755843 [No Abstract] [Full Text] [Related]
5. [Experiences with hexobendine in the treatment of coronary diseases]. Beckschäfer W Arzneimittelforschung; 1968 Aug; 18(8):1079-80. PubMed ID: 5755841 [No Abstract] [Full Text] [Related]
6. [Treatment of coronary heart disease from the modern point of view]. Dockweiler J Arzneimittelforschung; 1968 Aug; 18(8):1081-4. PubMed ID: 5755842 [No Abstract] [Full Text] [Related]
7. [Review of the literature and report of experiments relating to the coronaroactive drug, hexobendine]. Marmo E; Caputi AP; Cataldi S Minerva Cardioangiol; 1972 Oct; 20(10):571-81. PubMed ID: 4562623 [No Abstract] [Full Text] [Related]
8. [Coronary blood flow and oxygen consumption of human heart under the effect of hexobendine]. Rudolph W; Marko I; Baubkus H; Müller-Seydlitz P; Gadomski M; Posse P; Gulde M; Jetschgo G Arzneimittelforschung; 1970 May; 20(5):637-47. PubMed ID: 5468053 [No Abstract] [Full Text] [Related]
9. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease]. Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386 [No Abstract] [Full Text] [Related]
10. [Vasoactive combination treatment in cerebrovascular sclerosis]. Klein K Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190 [No Abstract] [Full Text] [Related]
11. [Results of clinical testing of carbochromen in chronic coronary insufficiency]. Schvacabaja IK; Mjasnikov LA; Metelica VI; Grigorjanc RA Arzneimittelforschung; 1970 Mar; 20():449-51. PubMed ID: 4916579 [No Abstract] [Full Text] [Related]
12. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270 [No Abstract] [Full Text] [Related]
13. [New drug (Sensit) for the treatment of coronary disease in a double blind test]. Pillen D Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940 [No Abstract] [Full Text] [Related]
14. [Effect of ustimon on cerebral circulation]. Vas M; Solti F; Gara I Wien Klin Wochenschr; 1969 Jan; 81(4):69-72. PubMed ID: 5812950 [No Abstract] [Full Text] [Related]
15. [Clinical experiences with the vascular action of dihydroergocristine]. Tomasi AM; Baggioni GF; Pozzar C Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854 [No Abstract] [Full Text] [Related]
16. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients]. Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159 [No Abstract] [Full Text] [Related]
17. [Clinical and electrocardiographic studies on Ustimon treatment]. Leibetseder F Wien Klin Wochenschr; 1965 Oct; 77(43):839-44. PubMed ID: 5874523 [No Abstract] [Full Text] [Related]
18. [Actihaemyl as adjuvant in cardiac therapy]. Lordick H Munch Med Wochenschr; 1970 Feb; 112(7):298-300. PubMed ID: 5537795 [No Abstract] [Full Text] [Related]
19. [Influence of "coronary dilators" on the pathological St-T segmental changes in the ECG]. Deiwick HJ; Wilke KH; Knoche I Med Klin; 1967 Jun; 62(24):945-50. PubMed ID: 4968559 [No Abstract] [Full Text] [Related]
20. [Intravenous proscillaridin A in cardiotonic therapy of the senile heart]. Massoni G G Gerontol; 1968 Sep; 16(9):975-8. PubMed ID: 5754030 [No Abstract] [Full Text] [Related] [Next] [New Search]